Stereotactic radiosurgery and fractionated stereotactic radiotherapy: Comparison of efficacy and toxicity in 260 patients with brain metastases

Journal of Neuro-Oncology

Volumn 109, Issue 1, 2012, Pages 91-98

  Fokas, Emmanouil ^a,d   Henzel, Martin ^a   Surber, Gunnar ^c   Kleinert, Gabriele ^c   Hamm, Klaus ^c   Engenhart Cabillic, Rita ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Brain metastases; Hypofractionated; Local control; Stereotactic radiosurgery; Toxicity

Indexed keywords

DEXAMETHASONE; PREDNISOLONE;

ADULT; AGED; ALOPECIA; ARTICLE; BRAIN EDEMA; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PROGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEADACHE; HEARING IMPAIRMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NAUSEA; NEUROIMAGING; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PATIENT SAFETY; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIOSURGERY; RADIOTHERAPY; STEREOTACTIC PROCEDURE; VISUAL IMPAIRMENT; VOMITING;

BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864289573     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0868-6     Document Type: Article

References (25)

1. R Soffietti R Ruda E Trevisan 2008 Brain metastases: current management and new developments Curr Opin Oncol 20 676 684 18841050 10.1097/CCO. 0b013e32831186fe
2. S Scoccianti U Ricardi 2012 Treatment of brain metastases: review of phase III randomized controlled trials Radiother Oncol 102 168 179 21996522 10.1016/j.radonc.2011.08.041
3. ME Linskey DW Andrews AL Asher SH Burri D Kondziolka PD Robinson M Ammirati CS Cobbs LE Gaspar JS Loeffler M McDermott MP Mehta T Mikkelsen JJ Olson NA Paleologos RA Patchell TC Ryken SN Kalkanis 2010 The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 45 68 19960227 10.1007/s11060-009-0073-4
4. MP Mehta MN Tsao TJ Whelan DE Morris JA Hayman JC Flickinger M Mills CL Rogers L Souhami 2005 The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases Int J Radiat Oncol Biol Phys 63 37 46 16111570 10.1016/j.ijrobp.2005. 05.023 (Pubitemid 41583540)
5. H Aoyama H Shirato M Tago K Nakagawa T Toyoda K Hatano M Kenjyo N Oya S Hirota H Shioura E Kunieda T Inomata K Hayakawa N Katoh G Kobashi 2006 Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2483 2491 16757720 10.1001/jama.295.21.2483 1:CAS:528: DC%2BD28XlsV2ltbo%3D (Pubitemid 43854963)
6. M Kocher R Soffietti U Abacioglu S Villa F Fauchon BG Baumert L Fariselli T Tzuk-Shina RD Kortmann C Carrie M Ben Hassel M Kouri E Valeinis D van den Berge S Collette L Collette RP Mueller 2011 Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 134 141 21041710 10.1200/JCO.2010.30.1655
7. E Shaw C Scott L Souhami R Dinapoli R Kline J Loeffler N Farnan 2000 Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05 Int J Radiat Oncol Biol Phys 47 291 298 10802351 10.1016/S0360-3016(99)00507-6 1:STN:280:DC%2BD3c3mtlyjuw%3D%3D (Pubitemid 30236367)
8. AK Kwon SJ Dibiase B Wang SL Hughes B Milcarek Y Zhu 2009 Hypofractionated stereotactic radiotherapy for the treatment of brain metastases Cancer 115 890 898 19132728 10.1002/cncr.24082
9. A Fahrig O Ganslandt U Lambrecht G Grabenbauer G Kleinert R Sauer K Hamm 2007 Hypofractionated stereotactic radiotherapy for brain metastases: results from three different dose concepts Strahlenther Onkol 183 625 630 17960338 10.1007/s00066-007-1714-1 (Pubitemid 350124271)
10. A Ernst-Stecken I Jeske A Hess F Rodel O Ganslandt G Grabenbauer R Sauer K Brune I Blumcke 2007 Hypofractionated stereotactic radiotherapy to the rat hippocampus. Determination of dose response and tolerance Strahlenther Onkol 183 440 446 17680224 10.1007/s00066-007-1715-0 (Pubitemid 47230520)
11. H Aoyama H Shirato R Onimaru K Kagei J Ikeda N Ishii Y Sawamura K Miyasaka 2003 Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull Int J Radiat Oncol Biol Phys 56 793 800 12788187 10.1016/S0360-3016(03)00014-2 (Pubitemid 36677374)
12. YJ Kim KH Cho JY Kim YK Lim HS Min SH Lee HJ Kim HS Gwak H Yoo 2011 Single-dose versus fractionated stereotactic radiotherapy for brain metastases Int J Radiat Oncol Biol Phys 81 483 489 20800386 10.1016/j.ijrobp.2010.05.033
13. P Lindvall P Bergstrom PO Lofroth A TommyBergenheim 2009 A comparison between surgical resection in combination with WBRT or hypofractionated stereotactic irradiation in the treatment of solitary brain metastases Acta Neurochir (Wien) 151 1053 1059 10.1007/s00701-009-0325-2
14. AA De Salles M Hariz CL Bajada S Goetsch T Bergenheim M Selch FE Holly T Solberg DP Becker 1993 Comparison between radiosurgery and stereotactic fractionated radiation for the treatment of brain metastases Acta Neurochir Suppl (Wien) 58 115 118
15. K Tokuuye Y Akine M Sumi Y Kagami S Murayama H Nakayama H Ikeda M Tanaka S Shibui K Nomura 1998 Fractionated stereotactic radiotherapy of small intracranial malignancies Int J Radiat Oncol Biol Phys 42 989 994 9869220 10.1016/S0360-3016(98)00293-4 1:STN:280:DyaK1M%2FosVGltw%3D%3D (Pubitemid 29004139)
16. M Henzel MW Gross K Hamm G Surber G Kleinert T Failing G Strassmann R Engenhart-Cabillic 2006 Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study Neurosurgery 59 1188 1194 17277681 10.1227/01.NEU.0000245626.93215.F6 discussion 1194
17. E Fokas M Henzel K Hamm G Surber G Kleinert R Engenhart-Cabillic 2010 Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients Strahlenther Onkol 186 210 217 20165820 10.1007/s00066-010-2055-z
18. B Emami J Lyman A Brown L Coia M Goitein JE Munzenrider B Shank LJ Solin M Wesson 1991 Tolerance of normal tissue to therapeutic irradiation Int J Radiat Oncol Biol Phys 21 109 122 2032882 10.1016/0360-3016(91)90171-Y 1:STN:280:DyaK3M3js1CktA%3D%3D
19. SL Stafford BE Pollock JA Leavitt RL Foote PD Brown MJ Link DA Gorman PJ Schomberg 2003 A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery Int J Radiat Oncol 55 1177 1181 10.1016/S0360-3016(02)04380-8 (Pubitemid 36338281)
20. MA Manning RM Cardinale SH Benedict BD Kavanagh RD Zwicker C Amir WC Broaddus 2000 Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases Int J Radiat Oncol Biol Phys 47 603 608 10837942 10.1016/S0360-3016(00)00475-2 1:STN:280:DC%2BD3c3pvVKqsw%3D%3D (Pubitemid 30317477)
21. A Ernst-Stecken O Ganslandt U Lambrecht R Sauer G Grabenbauer 2006 Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity Radiother Oncol 81 18 24 16978720 10.1016/j.radonc.2006.08. 024 (Pubitemid 44540233)
22. DW Andrews CB Scott PW Sperduto AE Flanders LE Gaspar MC Schell M Werner-Wasik W Demas J Ryu JP Bahary L Souhami M Rotman MP Mehta WJ Curran Jr 2004 Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 1665 1672 15158627 10.1016/S0140-6736(04) 16250-8 (Pubitemid 38670323)
23. MP Mehta NA Paleologos T Mikkelsen PD Robinson M Ammirati DW Andrews AL Asher SH Burri CS Cobbs LE Gaspar D Kondziolka ME Linskey JS Loeffler M McDermott JJ Olson RA Patchell TC Ryken SN Kalkanis 2010 The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline J Neurooncol 96 71 83 19960229 10.1007/s11060-009-0062-7
24. DJ Brenner 2008 The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction Semin Radiat Oncol 18 234 239 18725109 10.1016/j.semradonc.2008.04.004
25. A Narayana J Chang K Yenice K Chan S Lymberis C Brennan PH Gutin 2007 Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases Stereotact Funct Neurosurg 85 82 87 17167236 10.1159/000097923 (Pubitemid 46398365)